Fundraising Fox

Cartography Biosciences

South San Francisco, US · 18 known investors

cartography.bio

Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.

AI & Machine LearningBiotechDeep TechMedical Devices

Founders & leadership

MMMax Mumbach
Max MumbachFounding Scientist, Target Discovery
JVJeffrey Verboon
Jeffrey VerboonFounding Scientist, Computational Biology
ASAnsu Satpathy
Ansu SatpathyFounder
KPKevin Parker
Kevin ParkerChief Executive Officer30 Under 30 2023
KP
Kevin Parker, PhDChief Executive Officer, Board Director; co-founder
AS
Ansuman Satpathy, MD, PhD𝕏Co-founder; Board Director
HC
Howard Chang𝕏Co-founder

Investors · 18

Also in the syndicate · 5

a16z Bio and HealthFinchley H.V.LG CorpLotte Holdings CVCWing Venture Capital

Funding

SEC filings, press & company announcements

$67M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Cartography Biosciences do?
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.
Who founded Cartography Biosciences?
Cartography Biosciences was founded by Max Mumbach, Jeffrey Verboon, Ansu Satpathy.
Who are Cartography Biosciences's investors?
Cartography Biosciences's investors include 8VC, Andreessen Horowitz, Artis Ventures, Global BioAccess Fund, HAWKTAIL, Pfizer Venture Investments, Wing, AME Cloud Ventures and 5 more.
How much funding has Cartography Biosciences raised?
Cartography Biosciences has disclosed $67M raised across 1 of its 2 known rounds.
Where is Cartography Biosciences headquartered?
Cartography Biosciences is headquartered in South San Francisco, US.